The research validates the approach of mapping and targeting newly identified gene control domains, known as Super-Enhancers, for drug discovery and development in cancer and other diseases.
http://eon.businesswire.com/news/eon/20130411005970/en/Syros-Pharmaceuticals-Announces-Publications-Cell-Related-Key
http://eon.businesswire.com/news/eon/20130411005970/en/Syros-Pharmaceuticals-Announces-Publications-Cell-Related-Key
No comments:
Post a Comment